Saturday, July 11, 2026

Drug profile · INN

bnt323

bnt323 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — bnt323
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

bnt323 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN bnt323

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. BNT323-01 Phase 3 · BioNTech SE · Endometrial cancer
  2. BNT327, BNT323 Phase 2 · BioNTech SE · Advanced Breast Cancer Metastatic Breast Cancer

Frequently asked questions

What is bnt323?

bnt323 is an FDA-listed pharmaceutical active ingredient.